Alcon (ALC) said Tuesday its Unity vitreoretinal cataract system, or Unity VCS, was approved by Health Canada for use in the country.
The platform combines vitreoretinal and cataract surgical innovations into a single integrated system, the company said.
Alcon said it expects to launch Unity VCS commercially in Canada in early 2026.
Price: 86.73, Change: -0.07, Percent Change: -0.08